These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38762708)

  • 21. Thrombotic Complications of COVID-19 Infection: A Review.
    Castro RA; Frishman WH
    Cardiol Rev; 2021; 29(1):43-47. PubMed ID: 32947478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study.
    Mansour A; Flecher E; Schmidt M; Rozec B; Gouin-Thibault I; Esvan M; Fougerou C; Levy B; Porto A; Ross JT; Para M; Manganiello S; Lebreton G; Vincentelli A; Nesseler N;
    Intensive Care Med; 2022 Aug; 48(8):1039-1052. PubMed ID: 35829723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
    Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet Count Rose While D-Dimer Levels Dropped as Deaths and Thrombosis Declined-An Observational Study on Anticoagulation Shift in COVID-19.
    Sjöström A; Wersäll JD; Warnqvist A; Farm M; Magnusson M; Oldner A; Ågren A; Antovic J; Bruzelius M
    Thromb Haemost; 2021 Dec; 121(12):1610-1621. PubMed ID: 33831964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status.
    Li W; Xu Z; Xiang H; Zhang C; Guo Y; Xiong J
    Aging (Albany NY); 2021 Mar; 13(7):9225-9242. PubMed ID: 33818421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
    Bohula EA; Berg DD; Lopes MS; Connors JM; Babar I; Barnett CF; Chaudhry SP; Chopra A; Ginete W; Ieong MH; Katz JN; Kim EY; Kuder JF; Mazza E; McLean D; Mosier JM; Moskowitz A; Murphy SA; O'Donoghue ML; Park JG; Prasad R; Ruff CT; Shahrour MN; Sinha SS; Wiviott SD; Van Diepen S; Zainea M; Baird-Zars V; Sabatine MS; Morrow DA;
    Circulation; 2022 Nov; 146(18):1344-1356. PubMed ID: 36036760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercoagulable viscoelastic blood clot characteristics in critically ill coronavirus disease 2019 patients and associations with thrombotic complications.
    Roh DJ; Eiseman K; Kirsch H; Yoh N; Boehme A; Agarwal S; Park S; Connolly ES; Claassen J; Wagener G
    J Trauma Acute Care Surg; 2021 Jan; 90(1):e7-e12. PubMed ID: 33009340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in plasma D-dimer level in severe SARS-CoV-2 infection can be an indicator of fibrinolysis suppression: Case reports.
    Manzoor D; Bui C; Makhoul E; Luthringer D; Marchevsky A; Volod O
    Medicine (Baltimore); 2021 Apr; 100(15):e25255. PubMed ID: 33847623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
    Violi F; Ceccarelli G; Cangemi R; Cipollone F; D'Ardes D; Oliva A; Pirro M; Rocco M; Alessandri F; D'Ettorre G; Lichtner M; Pignatelli P; Ferro D; Ruberto F; Lip GYH; Pugliese F; Mastroianni CM;
    Intern Emerg Med; 2021 Aug; 16(5):1231-1237. PubMed ID: 34218413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral anticoagulant therapy during and after coronary angioplasty the intensity and duration of anticoagulation are essential to reduce thrombotic complications.
    ten Berg JM; Hutten BA; Kelder JC; Verheugt FW; Plokker HW
    Circulation; 2001 Apr; 103(16):2042-7. PubMed ID: 11319192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.
    Roldán V; Marín F; Muiña B; Torregrosa JM; Hernández-Romero D; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2011 Jun; 57(25):2496-504. PubMed ID: 21497043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.
    García-Ortega A; Oscullo G; Calvillo P; López-Reyes R; Méndez R; Gómez-Olivas JD; Bekki A; Fonfría C; Trilles-Olaso L; Zaldívar E; Ferrando A; Anguera G; Briones-Gómez A; Reig-Mezquida JP; Feced L; González-Jiménez P; Reyes S; Muñoz-Núñez CF; Carreres A; Gil R; Morata C; Toledo-Pons N; Martí-Bonmati L; Menéndez R; Martínez-García MÁ
    J Infect; 2021 Feb; 82(2):261-269. PubMed ID: 33440207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of a Prognostic Score to Identify Hospitalized Patients with COVID-19 at Increased Risk for Bleeding.
    Demelo-Rodriguez P; Galeano-Valle F; Ordieres-Ortega L; Siniscalchi C; Martín Del Pozo M; Fidalgo Á; Gil-Díaz A; Lobo JL; De Ancos C; Monreal M; For The Riete-Bleeding Investigators
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical characteristics and risk factors for symptomatic venous thromboembolism in hospitalized COVID-19 patients: A multicenter retrospective study.
    Li JY; Wang HF; Yin P; Li D; Wang DL; Peng P; Wang WH; Wang L; Yuan XW; Xie JY; Zhou F; Xiong N; Shao F; Wang CX; Tong X; Ye H; Wan WJ; Liu BD; Li WZ; Li Q; Tang LV; Hu Y; Lip GYH;
    J Thromb Haemost; 2021 Apr; 19(4):1038-1048. PubMed ID: 33534149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence & outcomes of clinically significant bleeding events in critically ill COVID-19 patients receiving Therapeutic dose AntiCoagulanTs: A retrospective cohort study (INTerACT study).
    Singh A; Dhir A; Kajal K; Naik NB; Lazar MS; Puri GD; Soni SL; Neupane A; Ganesh V; Kaloria N; Saini K; Hazarika A; Mahajan V; Singla K; Bhalla A
    Indian J Med Res; 2022; 155(5&6):526-537. PubMed ID: 36124497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19).
    Al-Samkari H; Song F; Van Cott EM; Kuter DJ; Rosovsky R
    Am J Hematol; 2020 Dec; 95(12):1479-1485. PubMed ID: 32780525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study.
    Deitelzweig S; Luo X; Nguyen JL; Malhotra D; Emir B; Russ C; Li X; Lee TC; Ferri M; Wiederkehr D; Reimbaeva M; Barnes GD; Piazza G
    J Thromb Thrombolysis; 2022 May; 53(4):766-776. PubMed ID: 35489004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiplatelet agents and anticoagulants for hypertension.
    Shantsila E; Kozieł-Siołkowska M; Lip GY
    Cochrane Database Syst Rev; 2022 Jul; 7():CD003186. PubMed ID: 35900898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.